119th (2025–2027)
H.R. 9421
The Ban Abortion by Mail Act would prohibit doctors certified to prescribe mifepristone, a medication used for abortion, from dispensing it through mail or telehealth without an in-person visit with the patient. The bill also requires that providers have a medical license in the same state where the patient resides. Any provider who violates these requirements would lose their certification to prescribe the drug for at least two years. The legislation applies to all providers certified under the FDA's Risk Evaluation and Mitigation Strategies (REMS) program for mifepristone. The bill requires the Secretary of Health and Human Services to submit annual reports to Congress listing providers who lose their certification due to violations of these requirements or unsafe prescribing practices.